Recent genetic studies have implicated an active role for intrahepatic lipid accumulation in the pathogenesis of both polycystic ovary syndrome (PCOS) and cardiovascular disease. These new insights may provide novel (non)pharmacological opportunities for the prevention and treatment of PCOS and cardiovascular disease at both the societal and clinical level.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.tem.2024.10.005 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!